Remaining Materials. At the end of the period described in Section 14.5(f) or, if this Agreement is terminated prior to the First Commercial Sale, at the request and expense of Company, Licensee shall transfer to Company, all quantities of Licensed Products and/or Licensed Molecules in the possession of Licensee or its Affiliates (including, without limitation, clinical trial supplies and Licensed Products and/or Licensed Molecules intended for commercial sale). Licensee shall transfer to Company all such quantities of Licensed Products and/or Licensed Molecules without charge, except that Company shall pay the reasonable costs of shipping. Licensee shall have no obligation to alter the labeling of such Licensed Products and/or Licensed Molecules.
Appears in 5 contracts
Samples: Development and License Agreement (Immunomedics Inc), Development and License Agreement (Seattle Genetics Inc /Wa), Development and License Agreement (Immunomedics Inc)